Ryvu Therapeutics S.A. (WSE: RVU)
Poland flag Poland · Delayed Price · Currency is PLN
52.20
-1.30 (-2.43%)
Sep 27, 2024, 5:00 PM CET

Ryvu Therapeutics Market Cap

Ryvu Therapeutics has a market cap or net worth of 1.21 billion as of September 30, 2024. Its market cap has decreased by -14.98% in one year.

Market Cap
1.21B
Enterprise Value
1.01B
Revenue
82.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
52.20

Market Cap Chart

Since July 14, 2011, Ryvu Therapeutics's market cap has increased from 56.50M to 1.21B, an increase of 2,035.93%. That is a compound annual growth rate of 26.07%.

History

DateMarket Cap% Change
Sep 27, 20241.21B-9.22%
Dec 29, 20231.33B16.75%
Dec 30, 20221.14B1.70%
Dec 30, 20211.12B23.98%
Dec 30, 2020903.09M25.66%
Dec 30, 2019718.71M-16.36%
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 30, 2015 Pro Pro
Dec 30, 2014 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Krka, d. d. 18.06B
NEUCA S.A. 3.61B
Sopharma AD 2.17B
Synektik Spólka Akcyjna 1.59B
Celon Pharma S.A. 1.49B
Voxel S.A. 1.13B
Selvita S.A. 1.04B
Mercator Medical S.A. 557.89M
Market Cap Rankings